Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,270 | -36,896 | -29,110 | -20,577 | -11,653 |
| Depreciation Amortization | 148 | 631 | 371 | 257 | 136 |
| Accounts payable and accrued liabilities | 687 | -677 | 62 | 2,182 | 788 |
| Other Working Capital | 27,071 | 2,243 | 2,755 | 3,247 | 3,831 |
| Other Operating Activity | 537 | 6,009 | 3,915 | 455 | 522 |
| Operating Cash Flow | $24,173 | $-28,690 | $-22,007 | $-14,436 | $-6,376 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -106 | -248 | -176 | -176 | -6 |
| Investing Cash Flow | $-106 | $-248 | $-176 | $-176 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34 | 32 | 32 | 32 | 32 |
| Financing Cash Flow | $34 | $32 | $32 | $32 | $32 |
| Beginning Cash Position | 20,423 | 49,329 | 49,329 | 49,329 | 49,329 |
| End Cash Position | 44,524 | 20,423 | 27,178 | 34,749 | 42,979 |
| Net Cash Flow | $24,101 | $-28,906 | $-22,151 | $-14,580 | $-6,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,173 | -28,690 | -22,007 | -14,436 | -6,376 |
| Capital Expenditure | -106 | -248 | -176 | -176 | -6 |
| Free Cash Flow | 24,067 | -28,938 | -22,183 | -14,612 | -6,382 |